As a result of drug manufacturer Bausch Health discontinuing participation in the Medicaid Drug Rebate Program, MassHealth is no longer covering non-rebate medications from Bausch Health and its subsidiaries — and consistent with that, Point32Health will no longer cover the non-rebate medications listed below, effective beginning Oct. 15, 2025 for Tufts Health Together members.

Point32Health is end-dating authorizations as of Oct. 15 for medications that are part of Bausch Health’s Patient Assistance Program, which is available to help eligible Medicaid patients obtain their products and treatments. We advise you and your patients to seek access to medications that are no longer covered by MassHealth and Point32Health, but are available through the PAP, by contacting the program at 855-770-0424.

In cases where the drug is not available through the PAP and a generic alternative is available on the MassHealth covered drug list, Point32Health will offer coverage. If that medication requires prior authorization, Point32Health will automatically update the existing authorization to allow for use of the generic. Often, pharmacies will provide a generic alternative without a new prescription, but in the event a dispensing pharmacy does not, the prescribing physician will need to write a new prescription.  

In preparation for this change in medication coverage, Point32Health will notify impacted members.

Topical Medications

Oral Medications

Injectable or Intranasal

Medications

  • Acanya (clindamycin/benzoyl peroxide)
  • Altreno (tretinoin 0.05% lotion)
  • Anusol-HC (hydrocortisone hemorrhoidalcream)
  • Arazlo (tazarotene lotion)
  • Benzamycin (benzoylperoxide/erythromycin)
  • Bryhali (halobetasol lotion)
  • Cabtreo (clindamycin/adapalene/benzoyl peroxide)
  • Carac (fluorouracil 0.5% cream)
  • Clindagel (clindamycin gel)
  • Duobrii (halobetasol/tazarotene lotion)
  • Efudex (fluorouracil 5% cream)
  • Elidel (pimecrolimus)
  • Ertaczo (sertaconazole)
  • Jublia (efinaconazole)
  • Klaron (sulfacetamide 10% lotion)
  • Luzu (luliconazole)
  • Noritate (metronidazole 1% cream)
  • Onexton (clindamycin/benzoyl peroxide gel, gel pump)
  • Retin-A (tretinoin)
  • Retin-A Micro (tretinoin microspheres)
  • Uceris (budesonide rectal foam)
  • Vanos (fluocinonide 0.1% cream)
  • Xerese (acyclovir/hydrocortisone)
  • Ziana (clindamycin/tretinoin)
  • Zovirax (acyclovir cream, ointment)
  • Zyclara (imiquimod 2.5%, 3.75% cream)

 

  • Ancobon (flucytosine)
  • Aplenzin (bupropion hydrobromide ER)
  • Apriso (mesalamine 0.375- gram ER capsule)
  • Ativan (lorazepam tablet)
  • Cardizem CD (diltiazem ER capsule)
  • Cardizem LA (diltiazem ER tablet)
  • Cardizem (diltiazem)
  • Colazal (balsalazide)
  • Cuprimine (penicillamine capsule)
  • Cycloset (bromocriptine 0.8 mg tablet)
  • Demser (metyrosine)
  • Diuril (chlorothiazide suspension)
  • Edecrin (ethacrynic acid tablet)
  • Isordil (isosorbide dinitrate tablet)
  • Librax (chlordiazepoxide/clidinium)
  • Lodosyn (carbidopa)
  • Mestinon (pyridostigmine bromide tablet, ER tablet, solution)
  • Moviprep (polyethylene glycol- electrolyte solution)
  • Mysoline (primidone)
  • Pepcid (famotidine tablet)
  • Plenvu (polyethylene glycol- electrolyte solution)
  • Relistor (methylnaltrexone tablet)
  • Syprine (trientine 250 mg capsule)
  • Targretin (bexarotene)
  • Tasmar (tolcapone)
  • Tiazac ER (diltiazem)
  • Trulance (plecanatide)
  • Uceris (budesonide ER tablet)
  • Vaseretic (enalapril/hydrochlorothiazide)
  • Vasotec (enalapril)
  • Wellbutrin XL (bupropion hydrochloride ER 150 mg, 300 mg tablet)
  • Xifaxan (rifaximin 200 mg, 550 mg)
  • Zelapar (selegiline ODT)
  • Ammonul (sodium phenylacetate/sodium benzoate)
  • Migranal (dihydroergotamine nasal spray)
  • Relistor (methylnaltrexone injection)
  • Siliq (brodalumab)
  • Visudyne (verteporfin)
  • Zegalogue (dasiglucagon)

ER=extended release, ODT=orally disintegrating tablet